Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 50 percent. This is unchanged from the same period last year. The company reported quarterly sales of $17.336 million which missed the analyst consensus estimate of $17.954 million by 3.44 percent. This is a 8.34 percent decrease over sales of $18.914 million the same period last year.